Maintaining Safety with SARS-CoV-2 Vaccines

The vast majority of people who have received the Covid-19 vaccine to date have had self-limited local or low-grade systemic reactions that resolve within 2 or 3 days. A very small number of people have had serious anaphylactic reactions requiring catecholamine infusion and respiratory support. It i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2021-02, Vol.384 (7), p.643-649
Hauptverfasser:	Castells, Mariana C, Phillips, Elizabeth J
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergies Anaphylaxis Anaphylaxis - etiology Anaphylaxis - therapy Antigens Catecholamines Clinical trials COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects COVID-19 Vaccines - immunology Drug dosages Humans Hypersensitivity (immediate) Immunization Injections Lipids mRNA Vaccines Nanoparticles Polyethylene glycol Review Severe acute respiratory syndrome coronavirus 2 Vaccines Vaccines, Synthetic - adverse effects Vaccines, Synthetic - immunology Viral Vaccines - adverse effects Viral Vaccines - immunology Workers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!